Loading company…
Riskpilot
← Back to search
Sign in
Get full access
TREKANTEN LEGESENTER DA
DA
Active
Org 987488840
Vågsbygd Ringvei 100B, 4621 Kristiansand S
General medical practice activities · NACE 8621
Est. 2004
5 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 4,6M
+19% vs 2023
EBITDA margin
1.3%
+24% vs 2023
Equity ratio
23.3%
Financial strength
Net profit 2024
NOK 0
5 employees
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 4,6M
+19%
EBITDA
NOK 60K
+24%
Net profit
NOK 0
—
Total assets
NOK 703K
-56%
Equity
NOK 164K
+0%
Employees
5
—
Company information
Legal name
TREKANTEN LEGESENTER DA
Org number
987488840
Legal form
Ansvarlig Selskap Med Delt Ansvar
NACE code
8621 · General medical practice activities
Founded
17. november 2004
Share capital
—
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Deltakerne i fellesskap.
Company purpose
Å drive legekontor, samt alt hva dermed står i forbindelse, herunder gjennom aksjetegning eller på annen måte å delta i andre selskaper eller foretak.
Contact
Address
Vågsbygd Ringvei 100B, 4621 Kristiansand S
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Kristiansand
All Norway companies
Revenue
NOK millions
0M
1M
3M
4M
6M
3M
2020
4M
2021
4M
2022
4M
2023
5M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
3 431
3 733
3 860
3 835
4 578
Staff expenses
−1 675
−1 802
−1 892
−1 899
−2 108
EBITDA
19
18
45
49
60
Depreciation & amort.
−19
−14
−45
−49
−60
EBIT
0
4
0
−0
0
Net financials
−0
−2
0
0
−0
Profit before tax
−0
2
0
−0
0
Tax
−0
−0
−0
−0
−0
Net profit
−0
2
0
0
0
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 186
773
938
1 605
703
Equity
169
164
164
164
164
Long-term debt
0
0
0
0
0
Short-term debt
1 017
610
774
1 441
539
Total debt
1 017
610
774
1 441
539
Financial ratios
5-year trend
EBITDA margin
1.3%
This company
15.8%
Market median
-92% vs market
2020
2024
Equity ratio
23.3%
This company
38.2%
Market median
-39% vs market
2020
2024
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
2020
2024
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
2020
2024
Asset turnover
6.52×
This company
1.12×
Market median
+482% vs market
2020
2024
Debt / equity
3.29×
This company
0.62×
Market median
-431% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
KU
Kenneth Undhjem
Chief Executive Officer
Chief Executive Officer
2021
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Luiz Gustavo Revollo Saucedo
Individual
0%
0%
2015
Anders Øgrey Brandsdal
Individual
0%
0%
2015
Miriam Stensrød
Individual
0%
0%
2015
Solamed As
Company
0%
0%
2015
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of TREKANTEN LEGESENTER DA also hold positions in
0
other companies.
Person
Role here
Other companies
Kenneth Undhjem
Chief Executive Officer
0 companies